Free Trial

Legato Capital Management LLC Trims Stock Holdings in AvePoint, Inc. (NASDAQ:AVPT)

AvePoint logo with Computer and Technology background

Legato Capital Management LLC decreased its position in AvePoint, Inc. (NASDAQ:AVPT - Free Report) by 27.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 80,603 shares of the company's stock after selling 30,084 shares during the quarter. Legato Capital Management LLC's holdings in AvePoint were worth $1,164,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Northern Trust Corp increased its position in AvePoint by 9.4% in the fourth quarter. Northern Trust Corp now owns 1,160,554 shares of the company's stock worth $19,161,000 after buying an additional 99,725 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of AvePoint by 5.9% in the first quarter. Principal Financial Group Inc. now owns 78,396 shares of the company's stock worth $1,132,000 after acquiring an additional 4,348 shares during the period. Two Sigma Investments LP boosted its stake in shares of AvePoint by 155.5% in the fourth quarter. Two Sigma Investments LP now owns 108,192 shares of the company's stock worth $1,786,000 after acquiring an additional 65,852 shares during the period. Summit Investment Advisors Inc. boosted its stake in shares of AvePoint by 8.4% in the fourth quarter. Summit Investment Advisors Inc. now owns 13,475 shares of the company's stock worth $222,000 after acquiring an additional 1,042 shares during the period. Finally, Ameriprise Financial Inc. boosted its stake in shares of AvePoint by 282.9% in the fourth quarter. Ameriprise Financial Inc. now owns 45,751 shares of the company's stock worth $755,000 after acquiring an additional 33,801 shares during the period. Institutional investors own 44.49% of the company's stock.

Insider Buying and Selling

In other AvePoint news, insider Brian Michael Brown sold 35,000 shares of the company's stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $18.74, for a total transaction of $655,900.00. Following the sale, the insider directly owned 1,190,443 shares in the company, valued at $22,308,901.82. This represents a 2.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Jeff Epstein sold 500,000 shares of the company's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $18.77, for a total value of $9,385,000.00. Following the sale, the director owned 1,157,891 shares in the company, valued at approximately $21,733,614.07. This trade represents a 30.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 605,000 shares of company stock worth $11,315,600. Company insiders own 26.19% of the company's stock.

AvePoint Trading Up 0.3%

Shares of NASDAQ:AVPT traded up $0.06 during mid-day trading on Friday, reaching $18.56. The stock had a trading volume of 885,007 shares, compared to its average volume of 1,115,773. AvePoint, Inc. has a 1 year low of $9.38 and a 1 year high of $20.25. The business's 50 day moving average price is $18.73 and its 200 day moving average price is $17.26. The company has a market cap of $3.77 billion, a P/E ratio of -142.76 and a beta of 1.33.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on AVPT. Jefferies Financial Group began coverage on AvePoint in a research note on Monday, July 21st. They issued a "buy" rating and a $22.00 price objective for the company. The Goldman Sachs Group boosted their target price on AvePoint from $15.00 to $17.00 and gave the stock a "neutral" rating in a research report on Monday, May 12th. Cantor Fitzgerald upgraded AvePoint to a "strong-buy" rating in a research report on Friday. Finally, Scotiabank boosted their target price on AvePoint from $19.00 to $22.00 and gave the stock a "sector outperform" rating in a research report on Friday, May 9th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $18.17.

View Our Latest Stock Analysis on AVPT

AvePoint Company Profile

(Free Report)

AvePoint, Inc provides cloud-native data management software platform in North America, Europe, Middle East, Africa, and Asia Pacific. It also offers software-as-a-service solutions and productivity applications. The company offers modularity and cloud services architecture to address critical challenges and the management of data to organizations that leverage third-party cloud vendors, including Microsoft, Salesforce, Google, AWS, Box, DropBox, and others; license and support; and maintenance services.

Featured Stories

Institutional Ownership by Quarter for AvePoint (NASDAQ:AVPT)

Should You Invest $1,000 in AvePoint Right Now?

Before you consider AvePoint, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AvePoint wasn't on the list.

While AvePoint currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines